Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector-borne nematode diseases.
Neglected tropical diseases caused by parasitic nematodes inflict an immense health and socioeconomic burden throughout much of the developing world. Current estimates indicate that more than two billion people are infected with nematodes, resulting in the loss of 14 million disability-adjusted life years per annum. Although these parasites cause significant mortality, they primarily cause chronic morbidity through a wide range of severe clinical ailments. Treatment options for nematode infections are restricted to a small number of anthelmintic drugs, and the rapid expansion of anthelmintic mass drug administration raises concerns of drug resistance. Preservation of existing drugs is necessary, as well as the development of new treatment options and methods of control. We focus this review on how the democratization of CRISPR/Cas9 genome editing technology can be enlisted to improve our understanding of the biology of nematode parasites and our ability to treat the infections they cause. We will first explore how this robust method of genome manipulation can be used to newly exploit the powerful model nematode Caenorhabditis elegans for parasitology research. We will then discuss potential avenues to develop CRISPR/Cas9 editing protocols in filarial nematodes. Lastly, we will propose potential ways in which CRISPR/Cas9 can be used to engineer gene drives that target the transmission of mosquito-borne filarial nematodes.
Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA.
Mostafa
M
Zamanian
Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA.
Erik C
EC
Andersen
D000818:Animals; D030801:Animals, Genetically Modified; D000871:Anthelmintics / Q000627:therapeutic use; D064113:CRISPR-Cas Systems; D017173:Caenorhabditis elegans / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D004605:Elephantiasis, Filarial / Q000469:parasitology / Q000517:prevention & control / Q000628:therapy; D005370:Filarioidea / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity; D000072669:Gene Editing / Q000379:methods* / Q000639:trends; D005818:Genetic Engineering; D049751:Genome, Helminth; D006801:Humans; D008957:Models, Genetic; D058069:Neglected Diseases / Q000517:prevention & control / Q000628:therapy; D009348:Nematoda / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity; D009349:Nematode Infections / Q000469:parasitology / Q000517:prevention & control* / Q000628:therapy*
D000871:Anthelmintics
CRISPR; filariasis; gene drives; mosquito; neglected tropical diseases